Corporate Reputation & Brand Purpose
CIIE 2024: Key Reputation Opportunities for Big Pharma
November 26, 2024
| Wendy Yu, Group Account Director, Healthcare, WE Red Bridge
Why Gen Alpha Will Fuel Spending This Season
October 31, 2024
| Wendy Joong, Senior Vice President, Consumer
Why Reputation Is a Business Driver in Healthcare
October 28, 2024
| Christina Corso, Executive Vice President, Health
Overcoming the Lack of Diversity in Clinical Trials
May 21, 2024
| Christina Corso, Executive Vice President, Health, Jocelyn Jackson, Senior Director, Insights & Analytics
Is Corporate Purpose Still Relevant in 2024?
March 28, 2024
| Libby Woolnough, Group Head - Corporate Reputation & Brand Purpose, WE Communications Australia
ESG Is Now Essential to B2B Business Success in China
January 22, 2024
| Nicky Wang, CEO, WE Red Bridge
Tech, Trials and Temperatures
November 09, 2023
| Shannon O’Shea, Senior Vice President, Sustainability, US
Why Sustainability and Transparency Go Hand in Hand
August 01, 2023
| Libby Woolnough, Group Head - Corporate Reputation & Brand Purpose, WE Communications Australia
Break Down Silos to Advance Sustainability
June 20, 2023
| Rebecca Wilson, former EVP, International
Healthy Reputations: The Foundation of Biotech and Pharma Firms’ Future
April 25, 2023
| Nitin Mantri, Regional Executive Managing Director for Asia-Pacific, WE and Group CEO, Avian WE
